Superstring Capital Management’s Immunogen IMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding IMGN
Superstring Capital Management's IMGN Position: Q1 2024 in Review
Superstring Capital Management sold out of Immunogen (IMGN) in Q1 2024, closing a stake of 598,072 shares — an estimated $17.7M sold.
Superstring Capital Management first reported a position in IMGN in Q4 2023 and held it in 1 quarter. The position peaked at $17.7M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.
- Superstring Capital Management reported no remaining Immunogen position as of Q1 2024 after selling out during the quarter.
- Superstring Capital Management sold 598,072 Immunogen shares in Q1 2024, an estimated $17.7M.
- Superstring Capital Management first reported a position in Immunogen in Q4 2023 and held it in 1 quarter.
- Superstring Capital Management's Immunogen position peaked at $17.7M in Q4 2023.
- 3 funds tracked by Wall St. Rank held Immunogen as of Q1 2024.
Based on Superstring Capital Management's 13F filing for Q1 2024, filed 15 May 2024.